Kolexia
Stern Marc-Henri Médecine générale
Stern Marc-Henri
Médecine générale
Clcc Institut Curie
Paris, France
164 Activités
472 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mélanome Tumeurs du sein Tumeurs de l'uvée Tumeurs de l'ovaire Métastase tumorale Carcinomes Tumeurs du sein triple-négatives Prédisposition génétique à une maladie Cellules tumorales circulantes

Collaborateurs

Voir plus
Rodrigues Manuel
Rodrigues Manuel
Clcc Institut Curie, Paris, France
Vincent-Salomon Anne
Vincent-Salomon Anne
Clcc Institut Curie, Paris, France
Stoppa-Lyonnet Dominique
Stoppa-Lyonnet Dominique
Clcc Institut Curie, Paris, France
Bidard Francois-Clement
Bidard Francois-Clement
Clcc Institut Curie, Paris, France

Industries

Voir plus
AstraZeneca
2 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
RadioPARP: A Phase I of Olaparib With Radiation Therapy in Patients With Inflammatory, Loco-regionally Advanced or Metastatic TNBC (Triple Negative Breast Cancer) or Patient With Operated TNBC With Residual Disease
Essai Clinique (AstraZeneca)   29 janvier 2024
Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0): Study to Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (R0)
Essai Clinique (Institut Curie)   29 janvier 2024
Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement.
Breast (Edinburgh, Scotland)   10 décembre 2023
Familial uveal melanoma and other tumours in 25 families with monoallelic germline MBD4 variants.
Journal of the National Cancer Institute   07 décembre 2023
187P Local and systemic anti-tumor response during tumor development in an immune privileged site: The case of uveal melanoma
Abstract Book of the ESMO Immuno-Oncology Congress 2023 6-8 December 2023   01 décembre 2023
180P Immunogenomic profiling of the randomized NeoPembrOv clinical trial reveals the VEGFR2 angiogenic axis as a promising actionable target to overcome immunoresistance of high-grade ovarian carcinomas
Abstract Book of the ESMO Immuno-Oncology Congress 2023 6-8 December 2023   01 décembre 2023
Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial.
Oncogene   09 novembre 2023
Mosaic promoter methylation contribution in hereditary breast/ovarian cancer pedigrees.
Journal of medical genetics   25 septembre 2023
Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma.
Cell reports   13 septembre 2023
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response.
Nature genetics   31 juillet 2023